chr1-207044014-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_018566.4(YOD1):​c.*5006A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.61 in 152,426 control chromosomes in the GnomAD database, including 30,033 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.61 ( 29982 hom., cov: 32)
Exomes 𝑓: 0.48 ( 51 hom. )

Consequence

YOD1
NM_018566.4 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.43

Publications

12 publications found
Variant links:
Genes affected
YOD1 (HGNC:25035): (YOD1 deubiquitinase) Protein ubiquitination controls many intracellular processes, including cell cycle progression, transcriptional activation, and signal transduction. This dynamic process, involving ubiquitin conjugating enzymes and deubiquitinating enzymes, adds and removes ubiquitin. Deubiquitinating enzymes are cysteine proteases that specifically cleave ubiquitin from ubiquitin-conjugated protein substrates. The protein encoded by this gene belongs to a DUB subfamily characterized by an ovarian tumor (OTU) domain. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2013]
PFKFB2 (HGNC:8873): (6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2) The protein encoded by this gene is involved in both the synthesis and degradation of fructose-2,6-bisphosphate, a regulatory molecule that controls glycolysis in eukaryotes. The encoded protein has a 6-phosphofructo-2-kinase activity that catalyzes the synthesis of fructose-2,6-bisphosphate, and a fructose-2,6-biphosphatase activity that catalyzes the degradation of fructose-2,6-bisphosphate. This protein regulates fructose-2,6-bisphosphate levels in the heart, while a related enzyme encoded by a different gene regulates fructose-2,6-bisphosphate levels in the liver and muscle. This enzyme functions as a homodimer. Two transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.806 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
YOD1NM_018566.4 linkc.*5006A>G 3_prime_UTR_variant Exon 2 of 2 ENST00000315927.9 NP_061036.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
YOD1ENST00000315927.9 linkc.*5006A>G 3_prime_UTR_variant Exon 2 of 2 1 NM_018566.4 ENSP00000326813.4

Frequencies

GnomAD3 genomes
AF:
0.611
AC:
92753
AN:
151900
Hom.:
29938
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.814
Gnomad AMI
AF:
0.484
Gnomad AMR
AF:
0.560
Gnomad ASJ
AF:
0.645
Gnomad EAS
AF:
0.248
Gnomad SAS
AF:
0.393
Gnomad FIN
AF:
0.570
Gnomad MID
AF:
0.652
Gnomad NFE
AF:
0.547
Gnomad OTH
AF:
0.634
GnomAD4 exome
AF:
0.483
AC:
197
AN:
408
Hom.:
51
Cov.:
0
AF XY:
0.463
AC XY:
114
AN XY:
246
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.483
AC:
194
AN:
402
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.500
AC:
1
AN:
2
Other (OTH)
AF:
0.500
AC:
2
AN:
4
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
5
10
15
20
25
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.611
AC:
92856
AN:
152018
Hom.:
29982
Cov.:
32
AF XY:
0.605
AC XY:
44957
AN XY:
74290
show subpopulations
African (AFR)
AF:
0.814
AC:
33793
AN:
41528
American (AMR)
AF:
0.559
AC:
8545
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.645
AC:
2236
AN:
3464
East Asian (EAS)
AF:
0.247
AC:
1280
AN:
5180
South Asian (SAS)
AF:
0.393
AC:
1892
AN:
4818
European-Finnish (FIN)
AF:
0.570
AC:
6017
AN:
10550
Middle Eastern (MID)
AF:
0.653
AC:
192
AN:
294
European-Non Finnish (NFE)
AF:
0.547
AC:
37125
AN:
67888
Other (OTH)
AF:
0.633
AC:
1335
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1703
3405
5108
6810
8513
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
736
1472
2208
2944
3680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.574
Hom.:
12604
Bravo
AF:
0.621
Asia WGS
AF:
0.347
AC:
1209
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
11
DANN
Benign
0.79
PhyloP100
1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1044145; hg19: chr1-207217359; COSMIC: COSV60006631; API